These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 762427)

  • 1. Differences in the behavior of the membrane and membrane-associated filamentous structures in normal and chronic lymphocytic leukemia (CLL) lymphocytes.
    Zucker-Franklin D; Liebes LF; Silber R
    J Immunol; 1979 Jan; 122(1):97-107. PubMed ID: 762427
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell membrane fluidity in chronic lymphocytic leukemia (CLL) lymphocytes and its relation to membrane receptor expression.
    Daefler S; Krueger GR; Mödder B; Deliconstantinos G
    J Exp Pathol; 1987; 3(2):147-54. PubMed ID: 2961855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural comparison of the cell coat in normal and chronic lymphocytic leukaemic blood lymphocytes by Concanavalin A labelling and cationic staining.
    Calman F
    Pathol Eur; 1975; 10(3):203-14. PubMed ID: 52860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered function and membrane properties of lymphocytic leukemia cells. Correlation with clinical stage of disease.
    Prokocimer M; Polliack A; Rosenkovitch E; Ben-Bassat H
    Isr J Med Sci; 1982 Jul; 18(7):746-52. PubMed ID: 7107217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of 5'-nucleotidase activity in lymphocytes in chronic lymphocytic leukemia.
    Lopes J; Zucker-Franklin D; Silber R
    J Clin Invest; 1973 May; 52(5):1297-300. PubMed ID: 4700498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic lymphocytic leukemia lymphocytes: membrane anomalies and H2O2 vulnerability.
    Silber R; Stahl RL; Farber CM; Kanganis D; Astrow A; Liebes LF
    Blood Cells; 1984; 10(2-3):233-9. PubMed ID: 6336165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell membrane markers in acute lymphoid leukemia in relapse.
    De Rossi G; Guglielmi C; Pasqualetti D; Lopez M; Mandelli F
    Biomedicine; 1981 Oct; 35(5):156-8. PubMed ID: 6947827
    [No Abstract]   [Full Text] [Related]  

  • 8. Freeze-fracture and microviscosity of lymphocyte membranes in myasthenia gravis.
    Shimizu Y
    Tokai J Exp Clin Med; 1980 Apr; 5(2):195-209. PubMed ID: 6968107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribonucleotide content of mononuclear cells from normal subjects and patients with chronic lymphocytic leukemia: increased nicotinamide adenine dinucleotide concentration in chronic lymphocytic leukemia lymphocytes.
    Liebes LF; Krigel RL; Conklyn M; Nevrla DR; Silber R
    Cancer Res; 1983 Nov; 43(11):5608-17. PubMed ID: 6604577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystalloid immunoglobulin inclusions in chronic lymphocytic leukemia.
    Makoui C; Mohanty LB
    Arch Pathol Lab Med; 1980 Aug; 104(8):442. PubMed ID: 6893139
    [No Abstract]   [Full Text] [Related]  

  • 11. Human lymphocyte surface immunoglobulin capping. Normal characteristics and anomalous behavior of chronic lymphocytic leukemic lymphocytes.
    Cohen HJ
    J Clin Invest; 1975 Jan; 55(1):84-93. PubMed ID: 1088910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative analysis of membrane glycoproteins of normal and chronic lymphatic leukemia B lymphocytes by lectins].
    de Dios I; Manso M; Martín M; López-Borrasca A
    Rev Esp Fisiol; 1985 Jun; 41(2):211-6. PubMed ID: 3875881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SEM observation of cultured, mitogen-stimulated leukocytes. Cells obtained from patients with acute myeloblastic and chronic lymphocytic leukemias.
    Lalague ED; Abugaber AA; Haviernick S; Corvellec MR; Pelletier L; Derghazarian C; Cousineau GH
    Experientia; 1982 Jan; 38(1):90-2. PubMed ID: 6948687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of dehydroascorbic acid transport to cell lineage in lymphocytes from normal subjects and patients with chronic lymphocytic leukemia.
    Stahl RL; Farber CM; Liebes LF; Silber R
    Cancer Res; 1985 Dec; 45(12 Pt 1):6507-12. PubMed ID: 4063995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone marrow restricted chronic lymphocytic leukemia (author's transl)].
    Hurtado Monroy R; Ruíz Argüelles G; Labardini Méndez JR
    Rev Invest Clin; 1980; 32(2):205-11. PubMed ID: 7423078
    [No Abstract]   [Full Text] [Related]  

  • 16. Surface structure of normal and leukaemic lymphocytes. I. Effect of mitogens.
    Holt PJ; Pal SG; Catovsky D; Lewis SM
    Clin Exp Immunol; 1972 Apr; 10(4):555-70. PubMed ID: 5034244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Freeze-etching assay of surface characteristics of normal and leukaemic lymphocytes (author's transl)].
    Renau-Piqueras J; Martínez-Ramon A; Forteza-Bover G
    Sangre (Barc); 1975; 20(4):425-36. PubMed ID: 1216073
    [No Abstract]   [Full Text] [Related]  

  • 18. Restoration of "normal" membrane function in CLL cells by patients' serum.
    Lewis CM; Pegrum GD
    Clin Exp Immunol; 1977 Feb; 27(2):285-91. PubMed ID: 849658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol modulation of membrane fluidity and ecto-nucleotide triphosphatase activity in human normal and CLL lymphocytes.
    Deliconstantinos G; Daefler S; Krueger GR
    Anticancer Res; 1987; 7(3 Pt B):347-52. PubMed ID: 2957950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Morphofunctional characteristics of lymphocytes in patients with acute and chronic lymphoid leukemia].
    Kozinets GI; Shishkanova ZG; Dul'tsina SM; Zakharova AV; Bykova IA
    Sov Med; 1981; (9):15-20. PubMed ID: 6947442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.